A route to laser angioplasty in the presence of fluoroscopy contrast media, using a nanosecond-pulsed 355-nm laser. Herzog A, Steinberg I, Gaisenberg E, Nomberg R, Ishaaya AA. Selective tissue ablation using laser radiation at 355 nm in lead extraction by a hybrid catheter a preliminary report. Herzog A, Bogdan S, Glikson M, Ishaaya AA, Love C. Acute and 30-day safety and effectiveness evaluation of Eximo Medical’s B-Laser™, a novel atherectomy device, in subjects affected with infrainguinal peripheral arterial disease: Results of the EX-PAD-03 trial. Shammas NW, Chandra P, Brodmann M, Weinstock B, Sedillo G, Cawich I, et al. Novel laser-based catheter for peripheral atherectomy: 6-month results from the Eximo Medical B-Laser™ IDE study. Rundback J, Chandra P, Brodmann M, Weinstock B, Sedillo G, Cawich I, et al. To read this article on click here.References: 1. Click to get this free reportĪngioDynamics, Inc. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. This could be one of the biggest buying opportunities of this decade, especially for those who get in early. Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking. Right now, investors in these companies have a shot at serious profits. The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. These Stocks Are Poised to Soar Past the Pandemic Merit Medical Systems’ long-term earnings-growth rate is estimated at 11.9%. The company presently carries a Zacks Rank #2. Surmodics’ long-term earnings-growth rate is estimated at 10%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The company presently carries a Zacks Rank #2 (Buy). OPKO Health’s long-term earnings-growth rate is estimated at 12%. Key PicksĪ few better-ranked stocks from the broader medical space include OPKO Health OPK, Surmodics SRDX and Merit Medical Systems MMSI. Shares of the Zacks Rank #3 (Hold) stock have lost 3.2% in the past three months against the industry’s rally of 9.2%. Per a Medgadget report, the global PAD market was valued at approximately $2.96 billion in 2018 and is expected to register 6.92% CAGR over the forecast period of 2018-2025. ![]() The company has already seen a very positive reception from initial users of the Auryon System across several markets and geographies. ![]() ![]() This technology has the capability to save limbs and enhance the quality of life for patients suffering from PAD. The solid-state, longer-wavelength and shorter-pulse approach makes the Auryon laser a more effective option across a wide array of plaque morphologies. The Auryon Atherectomy System for infrainguinal lesions and ISR has delivered impressive results without perforations, embolization or other major complications. The Auryon Atherectomy System’s solid-state laser technology will be made available to providers and patients nationwide. Management believes the Auryon Atherectomy System is path-breaking for the treatment of PAD. It uses solid-state laser technology for the treatment of PAD and is approved by the FDA with an indication for treatment of infrainguinal stenoses and occlusions, including ISR. The Auryon Atherectomy System leverages breakthrough technology to deliver treatment of PAD lesions and occlusions. This launch is expected to boost the company’s Vascular Interventions and Therapies segment. The Auryon Atherectomy System is the first laser atherectomy system to proficiently treat lesions of any type, length or location (above and below the knee), with minimal impact on vessel walls. ANGO recently launched the Auryon Atherectomy System, a newly developed path-breaking technology for the treatment of Peripheral Artery Disease (“PAD”), which includes Critical Limb Ischemia and In-Stent Restenosis (“ISR”).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |